TimesSquare Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

TimesSquare Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-418,980	Closed	-$38.5M	–	254
2015 Q3	$38.5M	Sell	418,980 -71,595	-15%	-$6.2M	0.24%	160
2015 Q2	$43.1M	Sell	490,575 -6,345	-1%	-$543K	0.23%	158
2015 Q1	$36.9M	Buy	496,920 +7,300	+1%	+$515K	0.2%	173
2014 Q4	$27.4M	Buy	489,620 +24,800	+5%	+$1.3M	0.15%	190
2014 Q3	$21.1M	Buy	464,820 +42,710	+10%	+$1.78M	0.12%	212
2014 Q2	$17.5M	Sell	422,110 -7,540	-2%	-$388K	0.09%	215
2014 Q1	$29.8M	Buy	429,650 +107,450	+33%	+$7.89M	0.16%	188
2013 Q4	$19.4M	Sell	322,200 -41,900	-12%	-$2.28M	0.1%	210
2013 Q3	$22.1M	Buy	364,100 +41,850	+13%	+$2.97M	0.12%	212
2013 Q2	$21.6M	Buy	+322,250	New	+$14.5M	0.13%	212

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TimesSquare Capital Management's CLVS Position: Q4 2015 in Review

TimesSquare Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2015, closing a stake of 418,980 shares — an estimated $38.5M sold.

TimesSquare Capital Management first reported a position in CLVS in Q2 2013 and held it in 10 quarters. The position peaked at $43.1M in Q2 2015. 157 funds tracked by Wall St. Rank hold CLVS as of Q4 2015.

TimesSquare Capital Management reported no remaining Clovis Oncology, Inc. position as of Q4 2015 after selling out during the quarter.
TimesSquare Capital Management sold 418,980 Clovis Oncology, Inc. shares in Q4 2015, an estimated $38.5M.
TimesSquare Capital Management first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 10 quarters.
TimesSquare Capital Management's Clovis Oncology, Inc. position peaked at $43.1M in Q2 2015.
157 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2015.

Based on TimesSquare Capital Management's 13F filing for Q4 2015, filed 11 Feb 2016.